ATE535517T1 - Benzolsulfonanilidverbindungen, die sich für die behandlung von erkrankungen eignen, die auf die modulation des serotonin-5-ht6-rezeptors ansprechen - Google Patents

Benzolsulfonanilidverbindungen, die sich für die behandlung von erkrankungen eignen, die auf die modulation des serotonin-5-ht6-rezeptors ansprechen

Info

Publication number: ATE535517T1
Authority: AT; Austria
Prior art keywords: serotonin; receptor; modulation; treatment; compounds suitable
Prior art date: 2007-11-02

Application number

AT08845310T

Other languages

English (en)

Inventor

Wilfried Braje

Sean Colm Turner

Andreas Haupt

Udo Lange

Karla Drescher

Karsten Wicke

Liliane Unger

Mario Mezler

Wolfgang Wernet

Matthias Mayrer

Ana Lucia Jongen-Relo

Anton Bespalov

Min Zhang

Original Assignee

Abbott Gmbh & Co Kg

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-11-02

Filing date

2008-10-31

Publication date

2011-12-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40340548&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE535517(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-10-31 Application filed by Abbott Gmbh & Co Kg, Abbott Lab filed Critical Abbott Gmbh & Co Kg

2011-12-15 Application granted granted Critical

2011-12-15 Publication of ATE535517T1 publication Critical patent/ATE535517T1/de

Links

QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title 2
108091005435 5-HT6 receptors Proteins 0.000 title 1
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
XAUGWFWQVYXATQ-UHFFFAOYSA-N n-phenylbenzenesulfonamide Chemical class C=1C=CC=CC=1S(=O)(=O)NC1=CC=CC=C1 XAUGWFWQVYXATQ-UHFFFAOYSA-N 0.000 title 1
229940076279 serotonin Drugs 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Obesity (AREA)
Psychology (AREA)
Diabetes (AREA)
Addiction (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Nutrition Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)

AT08845310T 2007-11-02 2008-10-31 Benzolsulfonanilidverbindungen, die sich für die behandlung von erkrankungen eignen, die auf die modulation des serotonin-5-ht6-rezeptors ansprechen ATE535517T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US165607P	2007-11-02	2007-11-02
PCT/EP2008/064811 WO2009056632A1 (en)	2007-11-02	2008-10-31	Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor

Publications (1)

Publication Number	Publication Date
ATE535517T1 true ATE535517T1 (de)	2011-12-15

Family

ID=40340548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT08845310T ATE535517T1 (de)	2007-11-02	2008-10-31	Benzolsulfonanilidverbindungen, die sich für die behandlung von erkrankungen eignen, die auf die modulation des serotonin-5-ht6-rezeptors ansprechen

Country Status (22)

Country	Link
US (2)	US7790727B2 (de)
EP (1)	EP2217583B1 (de)
JP (1)	JP2011502973A (de)
KR (1)	KR20100100849A (de)
CN (1)	CN101918384A (de)
AR (1)	AR069151A1 (de)
AT (1)	ATE535517T1 (de)
AU (1)	AU2008320821A1 (de)
BR (1)	BRPI0819233A2 (de)
CA (1)	CA2704529A1 (de)
CL (1)	CL2008003232A1 (de)
ES (1)	ES2378596T3 (de)
IL (1)	IL205469A0 (de)
MX (1)	MX2010004832A (de)
NZ (1)	NZ585087A (de)
PA (1)	PA8802201A1 (de)
PE (1)	PE20091016A1 (de)
RU (1)	RU2010122300A (de)
TW (1)	TW200927117A (de)
UY (1)	UY31447A1 (de)
WO (1)	WO2009056632A1 (de)
ZA (1)	ZA201003594B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PA8802201A1 (es) *	2007-11-02	2009-06-23	Abbott Gmbh & Co Kg	Compuestos de bencensulfonalida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6
US8183237B2 (en) *	2009-04-30	2012-05-22	Abbott Laboratories	Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor
CN105085436B (zh)	2014-04-19	2019-08-16	广东东阳光药业有限公司	磺酰胺类衍生物及其在药物上的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DZ2376A1 (fr) *	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
GB9818914D0 (en)	1998-08-28	1998-10-21	Smithkline Beecham Plc	Use
GB9818916D0 (en) *	1998-08-28	1998-10-21	Smithkline Beecham Plc	Use
SE0002739D0 (sv) *	2000-07-21	2000-07-21	Pharmacia & Upjohn Ab	New use
AU2005266448A1 (en) *	2004-07-28	2006-02-02	Glaxo Group Limited	Piperazine derivatives useful for the treatment of gastrointestinal disorders
PA8802201A1 (es) *	2007-11-02	2009-06-23	Abbott Gmbh & Co Kg	Compuestos de bencensulfonalida apropiados para tratar trastornos que responden a la modulacion del receptor de serotonina 5-ht6

2008
- 2008-10-29 PA PA20088802201A patent/PA8802201A1/es unknown
- 2008-10-29 CL CL2008003232A patent/CL2008003232A1/es unknown
- 2008-10-30 PE PE2008001857A patent/PE20091016A1/es not_active Application Discontinuation
- 2008-10-31 UY UY31447A patent/UY31447A1/es not_active Application Discontinuation
- 2008-10-31 NZ NZ585087A patent/NZ585087A/en not_active IP Right Cessation
- 2008-10-31 TW TW097142281A patent/TW200927117A/zh unknown
- 2008-10-31 AR ARP080104790A patent/AR069151A1/es not_active Application Discontinuation
- 2008-10-31 CA CA2704529A patent/CA2704529A1/en not_active Abandoned
- 2008-10-31 ES ES08845310T patent/ES2378596T3/es active Active
- 2008-10-31 KR KR1020107012151A patent/KR20100100849A/ko not_active Withdrawn
- 2008-10-31 CN CN2008801242091A patent/CN101918384A/zh active Pending
- 2008-10-31 RU RU2010122300/04A patent/RU2010122300A/ru not_active Application Discontinuation
- 2008-10-31 JP JP2010531536A patent/JP2011502973A/ja active Pending
- 2008-10-31 BR BRPI0819233A patent/BRPI0819233A2/pt not_active IP Right Cessation
- 2008-10-31 WO PCT/EP2008/064811 patent/WO2009056632A1/en not_active Ceased
- 2008-10-31 US US12/262,455 patent/US7790727B2/en not_active Expired - Fee Related
- 2008-10-31 EP EP08845310A patent/EP2217583B1/de not_active Not-in-force
- 2008-10-31 AT AT08845310T patent/ATE535517T1/de active
- 2008-10-31 AU AU2008320821A patent/AU2008320821A1/en not_active Abandoned
- 2008-10-31 MX MX2010004832A patent/MX2010004832A/es active IP Right Grant
2010
- 2010-04-29 IL IL205469A patent/IL205469A0/en unknown
- 2010-05-20 ZA ZA2010/03594A patent/ZA201003594B/en unknown
- 2010-08-05 US US12/851,466 patent/US20110086863A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BRPI0819233A2 (pt)	2017-05-02
IL205469A0 (en)	2010-12-30
PE20091016A1 (es)	2009-08-15
WO2009056632A1 (en)	2009-05-07
PA8802201A1 (es)	2009-06-23
UY31447A1 (es)	2009-05-29
JP2011502973A (ja)	2011-01-27
MX2010004832A (es)	2010-10-20
US7790727B2 (en)	2010-09-07
AR069151A1 (es)	2009-12-30
US20110086863A1 (en)	2011-04-14
NZ585087A (en)	2012-06-29
ZA201003594B (en)	2011-02-23
AU2008320821A1 (en)	2009-05-07
RU2010122300A (ru)	2011-12-10
CA2704529A1 (en)	2009-05-07
TW200927117A (en)	2009-07-01
CN101918384A (zh)	2010-12-15
EP2217583B1 (de)	2011-11-30
ES2378596T3 (es)	2012-04-16
KR20100100849A (ko)	2010-09-15
EP2217583A1 (de)	2010-08-18
CL2008003232A1 (es)	2009-11-27
US20090131452A1 (en)	2009-05-21

Publication	Publication Date	Title
LTC2137143I2 (lt)	2023-10-10	Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
EP2262508A4 (de)	2011-08-31	SUBSTITUIERTE p-CHINONDERIVATE ZUR BEHANDLUNG VON ERKRANKUNGEN IN VERBINDUNG MIT OXIDATIVEM STRESS
EP2091955A4 (de)	2013-01-02	Alkoxyverbindungen zur behandlung von erkrankungen
HUE039731T2 (hu)	2019-01-28	l,3-difenilprop-2-én-l-on-származékok alkalmazása májbetegségek kezelésére
DK2150530T3 (da)	2012-02-06	Substituerede sulfonamid-derivater
EA200901157A1 (ru)	2010-04-30	Конденсированные кольцевые гетероциклические модуляторы киназы
EP2720689A4 (de)	2014-11-26	Katecholderivate zur behandlung von erkrankungen in verbindung mit oxidativem stress
CR20130308A (es)	2014-02-13	Compuestos y su uso como inhibidores de bace
ZA201003110B (en)	2011-08-31	Novel cyclic hydrocarbon compounds for the treatment of diseases
MX2013012652A (es)	2014-05-27	Derivados de n-[(1h-pirazol-1-il)aril]-1h-indol o 1h-indazol-3-carboxamida, su preparacion y su uso como antagonistas p2y12.
DE602008000403D1 (de)	2010-01-28	Behandlung von medizinischen Implantaten, die kalkbeständig sind
MY149855A (en)	2013-10-31	Benzimidazole derivatives and their use for modulating the gaba? receptor complex
ATE541832T1 (de)	2012-02-15	Neuartige p2x7r-antagonisten und ihre verwendung
ATE534633T1 (de)	2011-12-15	Indazolderivate zur behandlung von hsp90- induzierten krankheiten
EA201100138A1 (ru)	2011-08-30	4-феноксиметилпиперидины в качестве модуляторов активности gpr119
MA32505B1 (fr)	2011-07-03	5-alcynyl-pyrimidines
EP2328417A4 (de)	2012-06-27	Verbindungen, zusammensetzungen und verfahren zur behandlung von beta-amyloid-vermittelten erkrankungen und synukleinopathien
MA32723B1 (fr)	2011-10-02	Derives d'anilino-pyrimidine a substitution sulfoximine en tant qu'inhibiteurs de cdk, leur preparation et leur utilisation comme medicaments
MX357504B (es)	2018-07-12	Derivado de feniltriazol y su uso para modular complejo del receptor gabaa.
MA32945B1 (fr)	2012-01-02	Tétrahydropyrane spiro pyrrolidinone et pipéridinone substituées, leur préparation et leur utilisation thérapeutique
IL201107A0 (en)	2010-05-17	Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor
ATE524456T1 (de)	2011-09-15	Zur behandlung von erkrankungen, die auf eine modulation des serotonin-5-ht6-rezeptors ansprechen, geeignete chinolinverbindung
EP2630150A4 (de)	2014-04-30	6-amido-derivat aus 4,5-a-epoxymorphinanen zur schmerzbehandlung
FR2953723B1 (fr)	2012-02-24	Composition pharmaceutique destinee au traitement des pathologies orthopediques
NO20083045L (no)	2008-09-04	Benzimidazolderivater og deres anvendelse til modulering av GABAA-reseptorkomplekset